Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Actions That Lead to an Excellent Diagnostic Experience Explored by The Beryl Institute


News Image

Reinforcing its commitment to elevate the human experience in healthcare, The Beryl Institute publishes a new white paper, A Global Inquiry on Excellence in the Diagnostic Journey: The Power of Human Experience in Healthcare. This paper is grounded in accounts from healthcare leaders, clinicians, staff, patients and family members on the actions and efforts that lead to excellence in the diagnostic experience. The white paper evaluates the diagnostic experience from a range of lenses including the scheduling and timing of appointments or procedures, the process of the experience overall, the environment in which the experience occurs, communication and engagement during the diagnostic journey and how results and planning are managed.

The goal of this global inquiry was to identify what matters most throughout the diagnostic experience and to identify, compare and contrast perspectives to better understand and act in ways that benefit all in healthcare. This inquiry followed a two-phase approach, starting with a diverse focus group conversation to help frame the broader context. The focus group’s responses then helped frame a survey that was conducted online.

The white paper illustrates key considerations for organizations and leaders to excel at the diagnostic experience, including:


  • How you communicate matters.
  • Take the time to be present for your patients.
  • Understand the priorities of your patients.
  • Ensure opportunities for partnership.

“It is in the ability of all in healthcare to remember the person traveling the diagnostic journey as just that: a human being with a story, loved ones, fears and dreams,” said Jason Wolf, Ph.D., CPXP, President & CEO of The Beryl Institute. “Each life is unique, even in the most common of diagnostic processes; therefore, each experience is unlike any other. It is in our ability to be present for one another with the foundational processes in place that will ensure not only the best in diagnostic experience but the best in human experience is delivered.”

To download the white paper, please visit: https://www.theberylinstitute.org/store/viewproduct.aspx?id=17422197

About The Beryl Institute:

The Beryl Institute is the global community of practice committed to elevating the human experience in healthcare. We believe human experience is grounded in experiences of patients & families, those who work in healthcare and the communities they serve. We define patient experience as the sum of all interactions, shaped by an organization’s culture, that influence patient perceptions across the continuum of care.

About Siemens Healthineers:

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. In fiscal 2019, which ended on September 30, 2019, Siemens Healthineers, which has approximately 52,000 employees worldwide, generated revenue of €14.5 billion and adjusted profit of €2.5 billion. Further information is available at http://www.siemens-healthineers.com

Share article on social media or email:

Bioclinica’s Client Services and Delivery Organization Led by Bradley Dean, SVP


News Image

“Brad’s deep experience and insight into our markets, along with his passion for exceeding our clients’ expectations, gives him a unique perspective as we deliver on our industry-leading service and capabilities,” said Euan Menzies, Chairman and CEO.

Bioclinica, an integrated solutions provider of clinical life science and technology expertise, delivering powerful insight into clinical trial development in bringing new therapies to people worldwide, today announced the new Client Services and Delivery organization, led by Brad Dean as Senior Vice President. The new organization will allow for all facets of client management and solution delivery to be unified by centralizing account management, project management, site services, clinical data management, and operations.

“Brad’s deep experience and insight into our markets, along with his passion for exceeding our clients’ expectations, gives him a unique perspective as we deliver on our industry-leading service and capabilities,” said Euan Menzies, Chairman and CEO.

Included in the organization is Bioclinica’s best-in-class project management team, focused on customer satisfaction and quality of services. Brad recently expanded this team by providing additional resources in Munich, Germany, to support studies outside the US.

“It is critical that we deliver our full suite of solutions, including our expanding capabilities to our clients in a high-quality manner,” said Brad. “We continue to build our team and retain strong talent, which is the foundation for service delivery and successful study outcomes.”

Brad has over 20 years of industry experience and has been with Bioclinica for the past 16 years. During his tenure, Brad has held positions of increasing responsibility in project management, pricing and proposals, mergers and acquisitions, and enterprise sponsors and portfolio management. Prior to joining Bioclinica, Brad held leadership positions in several clinical research organizations. In addition, he successfully served in the United States Peace Corps in Malawi, Africa as a Biology teacher.

About Bioclinica

Bioclinica is an integrated clinical life science solutions provider, delivering powerful insight into clinical trial development, assuring greater client success in bringing medical therapies to market for people around the world. Through deep medical, scientific and technology expertise, the company provides medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments; clinical trial management software; and drug safety solutions. Bioclinica’s global team of life science experts serve more than 500 pharmaceutical, biotechnology, and device organizations – including the top 20 biopharmaceutical companies and leading CROs – through offices in North America, Europe, and Asia. For more information, visit http://www.bioclinica.com.

Share article on social media or email:

PHA Promotes Awareness of Rare Form of Pulmonary Hypertension


As part of Pulmonary Hypertension Awareness Month, the Pulmonary Hypertension Association (PHA) has set aside Nov. 11 to help raise awareness and improve diagnosis of a rare form of pulmonary hypertension (PH). Unlike some forms of PH, chronic thromboembolic pulmonary hypertension (CTEPH) has treatment options that include a potentially curative surgery.

CTEPH is caused by blood clots in the lungs that harden over time and impede blood flow. Up to 5% of patients who develop a pulmonary embolism (or blood clot in their lungs) may develop CTEPH. Some patients with CTEPH have other changes in the small blood vessels in the lungs that make them narrower and stiffer. The clots stop or slow blood from flowing through the lungs and cause the right side of the heart to pump much harder, which can lead to right-heart failure and death.

Symptoms, including shortness of breath, fatigue and chest pain, are similar to other forms of pulmonary hypertension and more common respiratory ailments such as asthma. It is critical for anyone who has had a pulmonary embolism to know about symptoms of CTEPH and discuss with their physicians.

To accurately diagnose CTEPH, doctors must perform several tests. Those tests include a ventilation-perfusion (V/Q) scan that shows how blood circulates through the lungs to locate any areas of reduced blood flow and a right heart catheterization to measure blood pressure in the heart and lungs. CTEPH can be deadly but advances in treatment offer several options. One is a surgery that removes the chronic blood clots from the lungs.

“If left untreated, CTEPH is a deadly condition. Fortunately, it is perhaps the most treatable form of pulmonary hypertension, where even a cure is oftentimes possible,” said Gustavo Heresi, M.D., pulmonologist at Cleveland Clinic and director of the pulmonary hypertension program.

Dr. Heresi will participate in one of two Nov. 11 “Ask the Expert” Facebook Live events about CTEPH symptoms, diagnosis and treatments. The Spanish-language version, featuring Dr. Heresi and CTEPH patient Yanny Lopez, will take place at 10 a.m. EST.

At noon EST, an English version of the Q&A features Peter Hountras, M.D., of University of Colorado Hospital, and CTEPH patient Missy Storm. Watch at http://www.Facebook.com/PulmonaryHypertensionAssociation. Both events will be recorded and available afterward on the PHA website.

To learn more about CTEPH, visit PHAssociation.org/CTEPHDay. The day’s activities can also be followed on social media using #CTEPHDay.

About the Pulmonary Hypertension Association

Headquartered in Silver Spring, Md., the Pulmonary Hypertension Association (PHA) is the country’s oldest and largest nonprofit patient association dedicated to the pulmonary hypertension (PH) community. Pulmonary hypertension is a rare, chronic and life-threatening disease of the lungs for which no cure currently exists. PHA’s mission is to extend and improve the lives of those affected by PH. To achieve this mission, PHA engages people with PH and their families, caregivers, health care providers, and researchers worldwide who work together to advocate for the PH community, provide support to patients, caregivers and families, offer up-to-date education and information on PH, improve quality patient care, and fund and promote research. For more information, visit http://www.PHAssociation.org and connect with PHA on Twitter, Instagram, Facebook and LinkedIn.

Contact: PHA Communications

communications@phassociation.org

Share article on social media or email:



How to Stay Safe While Decorating and Lighting a Home for the Holidays


‘Tis the season to show holiday spirit with Christmas lights and holiday decorations. Before stringing up the lights, however, Christmas Decor —- a holiday decoration services franchise —- wants to help homeowners deck the halls as safely as possible.

In 2015, the Consumer Product Safety Commission reported six fatalities and an estimated 14,000 injuries treated in hospital ERs nationwide due to holiday decorations. Though falling from a ladder or getting zapped by a christmas bulb might be funny when it happens to Clark Griswald in the movies, these real-life scenarios can put a damper on the holiday cheer. That’s why it is so important to take the right precautions before creating a Christmas display. Here are a few safety protocols to follow this holiday season:

Use Precaution on a Ladder or Roof

If planning on hanging Christmas lights on the home’s exterior, be sure the ladder is in working order and is the correct height for use outside of the home. Be sure not to stretch while on the ladder, for it may lead to instability or imbalance. It is also important to check the security of the roof and ensure everything is in a stable, secure shape before climbing on top. Wearing a safety harness is also critical to keeping safe while creating a display. Should anything happen while hanging lights, the harness will want to ensure the decorator is protected from a fall.

“It’s best not to push your boundaries when it comes to ladder use,” said Brandon Stephens, President of Christmas Decor. “Know what you can handle and make sure the ladder is completely stable.”

Inspect Electrical Decorations

If hanging decorations is a yearly occurrence for the family, chances are the lights have been sitting in a box in the garage since last Christmas. Whether they are regular or LED lights, be sure to check that the circuitry is in good shape. More specifically, check for any nicks or cuts in the cable, damaged bulbs, and faulty sockets. On occasion, squirrels and other wildlife can gnaw and chew on the lights while they are in storage. By inspecting the equipment, the exterior of the home can be further protected from any sparks or unexpected fires that can occur from light damage.

Check the Weather

If the weather forecast indicates icy weather, consider the options for keeping safe. Exposure to the elements can cause more problems than harmful slips or falls — it can also cause frostbite or other health complications. Be sure to dress appropriately when hanging the lights to limit further exposure to cold or severe weather. Stephens explained: “Everyone worries about the ice, but you can catch a bad sickness from underdressing for the weather and sometimes even the right clothing won’t keep you safe. Pause your plans to decorate if the temperature is below freezing.”

Icy conditions are not ideal for ladder use, so either hang the lights earlier in the season or wait until any severe weather conditions pass before putting up the display. Ice can create instability when using a ladder, so check the ground before stepping up.

Recognize Personal Limits

For people who have never hung up their own display before and don’t feel comfortable doing it alone, hire a professional. The money spent on a decorating service is much less than a hospital bill, and this investment can keep everyone healthy and able to spend time with loved ones throughout the holiday season.

About Christmas Decor

Founded in 1986 by Blake Smith, Christmas Decor has become the leading holiday decorating brand in the U.S. and Canada. Originally created as an off-season supplement to the landscaping business, the Texas-based franchise now brings holiday cheer to over 300 communities across North America, ultimately creating jobs for 3,000-plus seasonal workers that might otherwise be unemployed. Backed by a strong business model and double-digit revenue increase year-over-year for the last 11 years, Christmas Decor is looking to grow in markets across the U.S. and Canada. For more information on Christmas Decor, please visit https://www.christmasdecor.net/franchise/.

Share article on social media or email:

AssetGenie, Inc. Donates COVID-19 Safety Supplies to Schools & Organizations in Need


Safety kits donated to schools nationwide.

As the need for food and shelter surges, we understand the increased demand placed on food kitchens and shelters during the pandemic. […] We want to support these organizations by safeguarding their staff and those in need against the virus.

In seeing the budgetary needs of school districts across the country and the associated state shortfalls, AssetGenie, Inc. (AGI) has partnered with over 100 school districts in need of COVID-19 safety products by supplying COVID-19 safety kits. Kits included sanitizer, stands and dispensers, masks, and floor decals. AGI will continue donating masks and hand sanitizer throughout the 2020-2021 school year.

“Many schools are facing budget constraints while having the seemingly insurmountable task of sanitizing and safeguarding their schools against COVID-19. If the budget is not the chief constraint, they could be having a difficult time finding supplies. By donating these supplies, we are hoping to help schools in a very real and tangible way,” said John Yetsconish, president of AGiRepair, a division of AGI.

As the virus surges in various states, AGI is seeking to expand this effort by donating safety supplies to homeless shelters, food kitchens, and women’s shelters nationally.

“As the need for food and shelter surges, we understand the increased demand placed on food kitchens and shelters during the pandemic. As more people fill these places and human interaction increases, we want to support these organizations by safeguarding their staff and those in need against the virus,” said Scott Dulon, president of AGParts Education, a division of AGI.

AGI hopes to partner with nonprofits by donating COVID-19 safety supplies so they can safely help as many people as possible.

Applications to apply are open on their website. If your nonprofit organization is in need of COVID-19 supplies, please visit: https://agigrouponline.com/covid-19-donations/.

About AssetGenie, Inc.

AssetGenie, Inc. is a global mobile device logistics company with offices in the US and China. AGI has three divisions: AGiRepair, AGParts Worldwide/AGParts Education, and AGDisplays. Our products and services include computer parts distribution, mobile device repair, 1:1 educational initiatives, custom LCD application design and solutions, and the management of reverse logistics services. Learn more at:

https://agigrouponline.com/.

Media Contact:

Jessica Szakos

Social Media & Content Coordinator

Share article on social media or email:

Nexcelom to Hold Virtual “Modern Cell-Based Assays” Symposium, November 10, 2020


Nexcelom to Hold Virtual “Modern Cell-Based Assays” Symposium, November 10, 2020.

Nexcelom Bioscience, experts in automated cell counting and analysis, invite you to the Modern Cell-Based Assays Symposium being held virtually on the LabRoots platform, November 10, 2020, at 8:00 am EST.

Whether you are working with cell culture, 3D assays, virology assays, or advanced cell models, there will be something for you at this engaging event. You will learn how to:

  • Conduct modern cell-based assays with varying culture models while maximizing the number of assays you can conduct as well as the number of measurable parameters.
  • Streamline your workflow with diversified technology that can be utilized across a variety of research areas.


Scientists from Nexcelom will join with other leading experts from academia, medicine, and industry to present on topics that include:

  • A Modern Approach to Traditional Virology Research
  • Engineering the Next Generation of Cells for Protein Production
  • Integration of Multimodal Imaging Platforms for the Study of Complex 3D Biological Systems
  • CD4 Chimeric Antigen Receptors to Re-direct CD4 T cells to Target HIV Infection
  • Turning Science into Medicine


Produced on LabRoots’ robust platform, connecting across all desktop and mobile devices, the symposium will also feature poster sessions to expand your knowledge base, virtual booths where you can engage with other professionals, as well as the opportunity to chat with Nexcelom field application scientists.

Participants in the Modern Cell-Based Assays symposium accumulate points for a chance to win prizes.

To register, click here.

About Nexcelom

Nexcelom Bioscience is the expert in automated cell counting and analysis. Since 2003, when Nexcelom’s founders introduced the CP2 to assist with manual cell counting, the company has expanded its automated Cellometer product range to accommodate researchers analyzing small cells, primary cells, and cell-based assays. With multiple patents pending, Nexcelom is a clear leader and innovator in the field of image-based cytometry for cell analysis. Thousands of customers, including the top ten pharmaceutical companies, have come to rely on Cellometer instruments for automated cell concentration and viability analysis.

About LabRoots

LabRoots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, LabRoots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events.

Share article on social media or email:

CISCRP Webinar About Clinical Trials Set for November 18 Featuring the Los Angeles Community


“We’re excited to be presenting this event,” said Joan Chambers, Senior Director at CISCRP. “The online program will answer a lot of key questions about the clinical research process, how clinical trials work, and what to expect as a study participant.”

CISCRP (Center for Information and Study on Clinical Research Participation) invites the Los Angeles Community to attend AWARE for All, a free webinar about clinical trials on Wednesday, November 18th, from 4-6PM PDT, via a customized, secure online platform.

CISCRP’s AWARE for All – Los Angeles program comes at a critically important time. Public interest in learning about clinical trials is high and the need for study volunteers in all disease conditions—including COVID-19 clinical trials—has increased significantly. The free program aims to inform and empower the public in understanding the clinical research process in order to make decisions about their health care. Led by CISCRP, a non-profit, and supported by local research organizations, advocacy groups and a consortium of biopharmaceutical and service provider companies, the educational program is open to all members of the public.

“We’re excited to be presenting this event,” said Joan Chambers, Senior Director at CISCRP. “The online program will answer a lot of key questions about the clinical research process, how clinical trials work, and what to expect as a study participant. Viewers will learn about clinical trials, straight from the patients and researchers who take part in them with a facilitated conversation and be able to submit questions via a chatbox during the program.”

Dr. Jonathan Jackson from Massachusetts General Hospital and the Harvard Medical School will be the overview speaker. In addition to the panel discussion, there will also be two – 5-minute health exercises and a virtual health fair with local and national community health advocates and researchers..

“Clinical research awareness is vital to the success of clinical trials,” added Dr. Jonathan Jackson, Ph.D., Director of Community Access, Recruitment, and Engagement (CARE) Research Center. “The success of clinical trials also depends on including a diverse and inclusive group of individuals representative of those who may receive the new therapy if it is approved for use.”

Paulette McDaniels is a clinical research participant and encourages others to learn as much as they can about a clinical trial before they decide to join. She also says you learn more about your own health and body in a clinical study, and that can help inform the study team. “It’s a team effort. If you aren’t working with your doctors and the team that’s doing the study, nobody is going to get anywhere,” says McDaniels.

Clinical research participant Jim Butler thanks his wife who brought the clinical trial opportunity to his attention and feels it was “an important way to be proactive about his diagnosis.” Jim referred to his research participation as something that he “feels really good about doing and is glad he can contribute to…”

AWARE for All – Los Angeles Clinical Research Webinar will be held Wednesday, November 18th, from 4-6pm PDT. Attendance is free, but please register today by clicking here. To learn more, visit awareforall.org or call 877-633-4376.

The AWARE for All – Los Angeles supporters include Allergy & Asthma Network, City of Hope, Pancreatic Cancer Action Network, PALS for Health, Alzheimer’s LA, Debbie’s Dream Foundation, Alliance for a Better Community, Being Alive LA, WeSPARK Cancer Support Center, Providence Clinical Research, Peer Plus, and the AWARE Industry Consortium.

About CISCRP

The Center for Information and Study on Clinical Research Participation (CISCRP) is a 501(c)(3) non-profit organization dedicated to engaging the public and patients as partners in the clinical research process. CISCRP provides free education and outreach to the general public and patient communities. Visit http://www.CISCRP.org for more information or to participate in CISCRP’s educational initiatives. For additional questions about AWARE for All, contact awareforall@ciscrp.org or call 877-633-4376.

###

Share article on social media or email:

Improving Access to Clinical Trials for Rare Disease Patients Through Registries, Upcoming Webinar Hosted by Xtalks


Research has shown that patients are likely to participate when they are aware of clinical trial opportunities and are empowered with knowledge to optimize their engagement experiences. In rare diseases, these problems are further amplified.

New medicines are made possible by participation in clinical trials and patient recruitment is often the rate limiting step in bringing new therapies to market. Research has shown that patients are likely to participate when they are aware of clinical trial opportunities and are empowered with knowledge to optimize their engagement experiences. In rare diseases, these problems are further amplified.

In this webinar, learn how Medidata is improving access to, and optimizing experiences in, clinical trials through myMedidata.

Join Kelly McKee, Senior Director of Patient Registries and Recruitment, Medidata – a Dassault Systèmes company – in a live webinar on Wednesday, November 18, 2020 at 1pm EST (10am PST).

For more information, or to register for this event, visit Improving Access to Clinical Trials for Rare Disease Patients Through Registries.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

The Evolving Role of Ion Channels in Shaping Successful Drug Discovery, Upcoming Webinar Hosted by Xtalks


Targeting ion channels selectively has always been challenging. New, more specific modalities including antibodies, aptamers, peptides and knotbodies are also being explored.

There are over 200 ion channels in the human body, all playing a pivotal role in normal physiology. As such, they are important targets for drug therapies that modulate ion channels in critical pathways, or correct aberrant ion channel function. To date, there are over 150 marketed drugs that target ion channels. Many of these drugs are anaesthetics, anti-epileptics or are active in the cardiovascular system.

The importance of ion channels in the pharmaceutical industry is evolving. As knowledge of ion channel physiology and how to target ion channels evolves, therapeutic opportunities are becoming more diverse, extending to renal and respiratory disease, inflammation, cancer, pain and depression. How the pharmaceutical industry tests and explores ion channels is also evolving with high-throughput platforms and hiPSC models.

Targeting ion channels selectively has always been challenging. New, more specific modalities including antibodies, aptamers, peptides and knotbodies are also being explored. Finally, given the importance of ion channels in normal physiology, unwanted activity at ion channels in the heart or CNS can cause serious adverse effects and should be avoided. In this respect, screening for effects on ion channels is a key, rapidly developing area of drug discovery.

Consideration of these evolving areas in ion channel drug discovery is critical to the successful development of new medicines.

Join Dr. Michael Morton, Director, ApconiX Ltd in a live webinar on Thursday, November 19, 2020 at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit The Evolving Role of Ion Channels in Shaping Successful Drug Discovery.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Challenges and Solutions in Host Cell Protein ELISA Development, Upcoming Webinar Hosted by Xtalks


Host Cell Proteins (HCPs) pose a common challenge to biopharmaceutical manufacturers as residual HCP can negatively influence the quality, safety and efficacy of drug products. The stepwise Downstream Processing (DSP) aims to purify the drug substance and requires the reliable monitoring of potential HCP impurities. This is usually carried out by an HCP ELISA as the method of choice, enabling an HCP measurement down to low ppm level. This method is based on antibodies that specifically detect HCP species in user-defined DSP samples which contain the drug substance. During ELISA development at BioGenes, a list of critical aspects is used to generate a powerful HCP assay. This includes the correct choice of a suitable mock antigen, a sophisticated immunization strategy, comprehensive reagent characterization and a targeted ELISA set-up.

Join featured speakers from BioGenes, Stefan Sommerschuh, Head of Assay Development; Pia Paarmann, PhD, Head of 2D Analytics; and Martin Föge, PhD, Business Development Manager, in a live webinar on Thursday, November 19, 2020 at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Challenges and Solutions in Host Cell Protein ELISA Development.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email: